Natalia Navarro

Single-cell profiling of alveolar rhabdomyosarcoma reveals RAS pathway inhibitors as cell-fate hijackers with therapeutic relevance

Sara G. Danielli, Ermelinda Porpiglia, Andrea J. De Micheli et al. · Science Advances · 2023 · 57 citations · Full text

Therapeutic Relevance, Cell-fate Hijackers, Cancer Biology +18

Ligand-dependent Hedgehog pathway activation in Rhabdomyosarcoma: the oncogenic role of the ligands

Ana Almazán-Moga, Patricia Zarzosa, Carla Molist et al. · British Journal of Cancer · 2017 · 34 citations · Full text

miRNA-7 and miRNA-324-5p regulate alpha9-Integrin expression and exert anti-oncogenic effects in rhabdomyosarcoma

Carla Molist, Natalia Navarro, Irina Giralt et al. · Cancer Letters · 2020 · 26 citations

Exert Anti-oncogenic Effects, Oncogenic Agent, Medicine +7

Integrin alpha9 emerges as a key therapeutic target to reduce metastasis in rhabdomyosarcoma and neuroblastoma

Natalia Navarro, Carla Molist, Júlia Sansa-Girona et al. · Cellular and Molecular Life Sciences · 2022 · 13 citations · Full text